Federal Register / Vol. 87, No. 47 / Thursday, March 10, 2022 / Notices 13735 

A. Federal Reserve Bank of Atlanta 

(Erien O. Terry, Assistant Vice 

President) 1000 Peachtree Street NE, 

Atlanta, Georgia 30309. Comments can 

also be sent electronically to 

Applications.Comments@atl.frb.org: 

1. Amanda Ligon Landry, Ethel, 

Louisiana; to join the Ligon Family 

Group, a group acting in concert, to 

acquire voting shares of Clinton 

Bancshares, Inc., and thereby indirectly 

acquire voting shares of Landmark 

Bank, both of Clinton, Louisiana. 

B. Federal Reserve Bank of San 

Francisco (Sebastian Astrada, Director, 

Applications) 101 Market Street, San 

Francisco, California 94105–1579: 

1. The BRP 2009 Trust, The Jared 

Goodale 2009 Trust, and The Myles 

Goodale 2009 Trust, Deana Rae 

Gillespie, as trustee of all trusts, all of 

Washington, Utah; to join the Penoske 

Family Control Group, a group acting in 

concert, to retain voting shares of 

Community Bancshares, Inc., and 

thereby indirectly retain voting shares of 

Community Bank, both of Joseph, 

Oregon. 

Board of Governors of the Federal Reserve 

System, March 7, 2022. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–05064 Filed 3–9–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project: ‘‘Online 

Application Order Form for Products 

from the Healthcare Cost and Utilization 

Project (HCUP).’’ This proposed 

information collection was previously 

published in the Federal Register on 

January 3rd, 2021 and allowed 60 days 

for public comment. During the 60 days, 

no substantive comments from members 

of the public were received by AHRQ. 

The purpose of this notice is to allow an 

additional 30 days for public comment. 

DATES: Comments on this notice must be 

received by April 11, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Online Application Order Form for 

Products From the Healthcare Cost and 

Utilization Project (HCUP) 

The Healthcare Cost and Utilization 

Project (HCUP, pronounced ‘‘H-Cup’’) is 

a vital resource helping the Agency 

achieve its research agenda, thereby 

furthering its goal of improving the 

delivery of health care in the United 

States. HCUP is a family of health care 

databases and related software tools and 

products developed through a FederalState-Industry partnership and 

sponsored by AHRQ. HCUP includes 

the largest collection of longitudinal 

hospital care data in the United States, 

with all-payer, encounter-level 

information beginning in 1988. The 

HCUP databases are annual files that 

contain anonymous information from 

hospital discharge records for inpatient 

care and certain components of 

outpatient care, such as emergency care 

and ambulatory surgeries. The project 

currently releases eight types of 

databases created for research use on a 

broad range of health issues, including 

cost and quality of health services, 

medical practice patterns, access to 

health care programs, and outcomes of 

treatments at the national, State, and 

local market levels. HCUP also produces 

a large number of software tools to 

enhance the use of administrative health 

care data for research and public health 

use. Software tools use information 

available from a variety of sources to 

create new data elements, often through 

sophisticated algorithms, for use with 

the HCUP databases. 

HCUP’s objectives are to: 

• Create and enhance a powerful 

source of national, state, and all-payer 

health care data. 

• Produce a broad set of software 

tools and products to facilitate the use 

of HCUP and other administrative data. 

• Enrich a collaborative partnership 

with statewide data organizations (that 

voluntarily participate in the project) 

aimed at increasing the quality and use 

of health care data. 

• Conduct and translate research to 

inform decision making and improve 

health care delivery. 

This project is being conducted by 

AHRQ through its primary contractor 

and subcontractor, IBM Watson Health 

and Pantheon Software, pursuant to 

AHRQ’s statutory authority to conduct 

and support research on healthcare and 

on systems for the delivery of such care, 

including activities with respect to the 

outcomes, cost, cost-effectiveness, and 

use of health care services and access to 

such services. 42 U.S.C. 299a(a)(3). 

Method of Collection 

The project currently creates eight 

types of restricted access public release 

databases and related files that are 

released to authorized users under the 

terms of the HCUP Data Use Agreement 

(DUA). These HCUP databases and files 

are used by researchers for a broad range 

of health issues, including cost and 

quality of health services, medical 

practice patterns, access to health care 

programs, and outcomes of treatments at 

the national, State, and local market 

levels. 

HCUP achieves the restricted access 

public release and tracking of the HCUP 

databases through the Online 

Application Form for HCUP Products 

(https://www.distributor.hcupus.ahrq.gov/SpecialPages/Shoppingcart.

aspx). To access the eight types of 

database, HCUP users are required to 

complete the Online Application Form 

for HCUP Products which includes 

three components, the application, 

HCUP DUA training (https://www.hcupus.ahrq.gov/DUA/dua/index.html) and 

signing a HCUP DUA. Users are 

required to sign one of two DUAs: (1) 

Nationwide or (2) state (hereafter 

referred to collectively as the HCUP 

DUA) after they complete the HCUP 

DUA training. 

Information collected in the HCUP 

Online Application Form process will 

be used for two purposes only: 

1. Business Transaction: In order to 

deliver the HCUP databases to the 

applicants, contact information is 

necessary for shipping the data on disk 

(or any other media used in the future) 

and payment collection. 

2. Enforcement of the HCUP Data Use 

Agreement (DUA): The HCUP DUA 

contains several restrictions on use of 

the data. Most of these restrictions have 

been put in place to safeguard the 

privacy of individuals and 

establishments represented in the data. 

For example, data users can only use the 

data for research, analysis, and aggregate 

statistical reporting and are prohibited 


khammond on DSKJM1Z7X2PROD with NOTICES
13736 Federal Register / Vol. 87, No. 47 / Thursday, March 10, 2022 / Notices 

from attempting to identify any persons 

in the data. Contact information on 

HCUP DUAs is retained in the event 

that a violation of the HCUP DUA takes 

place requiring legal remedy. 

Estimated Annual Respondent Burden 

Exhibit 1 shows the estimated 

annualized burden associated with the 

applicants’ time to order any of the 

HCUP databases. An estimated 1,800 

persons will order HCUP data annually. 

Each of these persons will complete 

Online Application Order Form for 

HCUP products (30 minutes). The total 

burden for the Online Application 

Order Form is estimated to be 900 hours 

annually. Exhibit 2 shows the estimated 

annualized cost burden associated with 

the applicants’ time to order HCUP data. 

The total cost burden is estimated to be 

$39,879 annually. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Total for the HCUP Data Purchase Ordering Form ........................................ 1,800 1 30/60 900 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Total ................................................................................................................. 1,800 900 $44.31 $39,879 

*Based upon the mean of the average wages for Life Scientists, All Other (19–1099), National Compensation Survey: Occupational Employment Statistics, May 2020 National Occupational Employment and Wage Estimates United States, U.S. Department of Labor, Bureau of Labor 

Statistics. https://www.bls.gov/oes/current/oes_nat.htm#19-0000. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: March 7, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–05122 Filed 3–9–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–1285] 

Oncologic Drugs Advisory Committee; 

Notice of Meeting; Establishment of a 

Public Docket; Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; establishment of a 

public docket; request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) announces a 

forthcoming public advisory committee 

meeting of the Oncologic Drugs 

Advisory Committee. The general 

function of the committee is to provide 

advice and recommendations to FDA on 

regulatory issues. The meeting will be 

open to the public. FDA is establishing 

a docket for public comment on this 

document. 

DATES: The meeting will be held 

virtually on April 21, 2022, from 12 

p.m. to 3:30 p.m. Eastern Time and 

April 22, 2022, from 9 a.m. to 1 p.m. 

Eastern Time. 

ADDRESSES: Please note that due to the 

impact of this COVID–19 pandemic, all 

meeting participants will be joining this 

advisory committee meeting via an 

online teleconferencing platform. 

Answers to commonly asked questions 

about FDA advisory committee meetings 

may be accessed at: https://

www.fda.gov/AdvisoryCommittees/ 

AboutAdvisoryCommittees/ucm408555.

htm. 

FDA is establishing a docket for 

public comment on this meeting. The 

docket number is FDA–2021–N–1285. 

The docket will close on April 20, 2022. 

Submit either electronic or written 

comments on this public meeting by 

April 20, 2022. Please note that late, 

untimely filed comments will not be 

considered. Electronic comments must 

be submitted on or before April 20, 

2022. The https://www.regulations.gov 

electronic filing system will accept 

comments until 11:59 p.m. Eastern Time 

at the end of April 20, 2022. Comments 

received by mail/hand delivery/courier 

(for written/paper submissions) will be 

considered timely if they are 

postmarked or the delivery service 

acceptance receipt is on or before that 

date. 

Comments received on or before April 

7, 2022, will be provided to the 

committee. Comments received after 

that date will be taken into 

consideration by FDA. In the event that 

the meeting is cancelled, FDA will 

continue to evaluate any relevant 

applications or information, and 

consider any comments submitted to the 

docket, as appropriate. 

You may submit comments as 

follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 


khammond on DSKJM1Z7X2PROD with NOTICES